Related posts
Most Anticipated Earnings: IAG-T, BDT-T and more Canadian Companies Reporting Earnings this Week (Nov 04-08)Most Anticipated Earnings: MRE-T, PSI-T and more Canadian Companies Reporting Earnings this Week (Aug 05-09).Most Anticipated Earnings: BLDP-T, BOS-T and more Canadian Companies Reporting Earnings this Week (May 06-10)Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Trades at under 2x sales and growth is positive. The stock is doing well. Debt remains high and they are losing money. Insiders are committed, owning 21% and continue to buy. The acquisition adds $170M to sales. Has held gains this year and is a better mid-cap name in the space. Unlock Premium - Try 5i Free
(A Top Pick Feb 24/20, Up 26%) It was Centric Health. It is a large position for him and a core holding. He would buy it again. There is powerful demographic tailwinds for them. They are consolidating a very fragmented industry in Canada. There are huge cost synergies.
Billy Kawasaki’s Insights - Picks from 5i Research. The company continues to transform and has done well. The market cap has grown and revenues should be over $200M next year. Debt remains high however, and it has negative cash flow. Top line growth over the next two years is expected to be in the range of 20%-30%. Unlock Premium - Try 5i Free
CareRx is a Canadian stock, trading under the symbol CRRX-T on the Toronto Stock Exchange (CRRX-CT). It is usually referred to as TSX:CRRX or CRRX-T
In the last year, there was no coverage of CareRx published on Stockchase.
CareRx was recommended as a Top Pick by on . Read the latest stock experts ratings for CareRx.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered CareRx In the last year. It is a trending stock that is worth watching.
On 2024-12-11, CareRx (CRRX-T) stock closed at a price of $2.